Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

578
Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
578
Hypertension I: Introduction01:28

Hypertension I: Introduction

676
Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
676
Errors occurring during blood pressure monitoring01:25

Errors occurring during blood pressure monitoring

1.3K
Blood pressure monitoring is a crucial clinical procedure in diagnosing and managing various cardiovascular conditions. Despite its significance, the accuracy of blood pressure measurements can be compromised by multiple factors, potentially leading to either falsely high or low readings. These inaccuracies are critical as they can significantly impact patient care. So, it is vital to understand these challenges deeply and adopt strategic approaches to minimize errors.
Several factors...
1.3K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

343
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
343
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

708
Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
708
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

3.6K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Modifiable Risk Factors and Attributable Ischemic Heart Disease Mortality in US States, 1990-2023: A Systematic Analysis for the Global Burden of Disease Study 2023.

JAMA cardiology·2026
Same author

Chandipura Virus: An Emerging Neurological Threat Transmitted by Sandflies in India.

Immunity, inflammation and disease·2026
Same author

Therapeutic targeting of COX-2 in head and neck cancer: Mechanistic and clinical perspectives.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2026
Same author

A Thematic Analysis of Key Informant Interviews on the Implementation Experience of the HEARTS Hypertension Program in Nigeria.

Global heart·2026
Same author

Precision pharmacology of CNS GPCRs: From biased signaling to translational therapeutics.

Progress in neuro-psychopharmacology & biological psychiatry·2026
Same author

Evidence-informed prioritization of interventions for integrating hypertension management into cardiovascular-kidney-metabolic care in primary health care: HEARTS 2.0 Phase 3.

American journal of hypertension·2026

Related Experiment Video

Updated: Jan 9, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K

Lessons Learned From Treating 34 Million People With Hypertension: The Global HEARTS Initiative.

Bolanle F Banigbe1, Andrew E Moran2, Reena Gupta3

  • 1Resolve to Save Lives, New York, New York, USA.

Journal of the American College of Cardiology
|December 3, 2025
PubMed
Summary

Effective hypertension control programs, like the World Health Organization HEARTS initiative, are crucial for reducing preventable deaths. Implementing these programs requires addressing medication access, provider training, and digital health systems for better blood pressure management.

Keywords:
HEARTS technical packagecardiovascular diseasehypertension treatmentlow- and middle-income countriesmyocardial infarctionstroke

More Related Videos

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

877

Related Experiment Videos

Last Updated: Jan 9, 2026

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion
08:35

Improved Renal Denervation Mitigated Hypertension Induced by Angiotensin II Infusion

Published on: May 26, 2022

4.0K
Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis
07:51

Hydra, a Computer-Based Platform for Aiding Clinicians in Cardiovascular Analysis and Diagnosis

Published on: September 26, 2018

8.0K
Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

877

Area of Science:

  • Public Health
  • Cardiovascular Medicine
  • Health Systems Strengthening

Background:

  • Hypertension is a leading cause of preventable death globally, with poor blood pressure (BP) control rates.
  • The World Health Organization (WHO) HEARTS technical package offers scalable interventions for hypertension management.
  • Resolve to Save Lives has supported HEARTS-based programs in 38 countries since 2017.

Purpose of the Study:

  • To describe barriers and facilitators of success in multi-country HEARTS-based hypertension control programs.
  • To share lessons learned from large-scale implementation of hypertension interventions.
  • To identify strategies for improving BP control rates globally.

Main Methods:

  • Collaboration with national governments and stakeholders to implement HEARTS programs.
  • Utilizing linear drug- and dose-specific treatment protocols.
  • Employing advocacy, mentoring, and digital information systems for program scale-up.

Main Results:

  • Over 34 million people initiated treatment across >220,000 facilities in 38 countries by December 2024.
  • Linear protocols proved effective, cost-saving, and enabled non-physician healthcare worker participation.
  • Key challenges included reliable access to affordable medicines and policy/institutional barriers to task shifting.

Conclusions:

  • Implementing country-developed protocols, improving drug supply chains, and investing in digital systems are critical for scaling hypertension control.
  • Addressing policy and institutional barriers through advocacy, training, and supervision is essential for team-based care and task shifting.
  • Strategies like eliminating user fees, decentralizing treatment, and integrating services can improve uptake, retention, and BP control, making 50% community BP control achievable.